Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Long Non-coding RNA GAS5 Functions as a Tumor Suppressor in Renal Cell Carcinoma

  • Qiao, Hui-Ping (School of Radiation Medicine and Protection, Medical College of Soochow University) ;
  • Gao, Wei-Shi (Surgical oncology, Inner Mongolia Autonomous Region Hospital) ;
  • Huo, Jian-Xin (Department of Radio-oncology, The First Affiliated Hospital of Baotou Medical College) ;
  • Yang, Zhan-Shan (School of Radiation Medicine and Protection, Medical College of Soochow University)
  • Published : 2013.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Renal cell carcinoma (RCC) is a malignancy with a poor prognosis. We aimed to explore whether the expression of Long Non-Coding RNA (LncRNA) growth arrest-specific transcript 5 (GAS5) is associated with RCC genesis. Methods: We selected twelve clinical samples diagnosed for renal clear cell carcinoma and found that the LncRNA GAS5 transcript levels were significantly reduced relative to those in adjacent unaffected normal renal tissues. Results: In addition, expression of GAS5 was lower in the RCC cell line A498 than that in normal renal cell line HK-2. Furthermore, using functional expression cloning, we found that overexpression of GAS5 in A498 cells inhibited cell proliferation, induced cell apoptosis and arrested cell cycling. At the same time, the migration and invasion potential of A498 cells were inhibited compared to control groups. Conclusion: Our study provided the first evidence that a decrease in GAS5 expression is associated with RCC genesis and progression and overexpression of GAS5 can act as a tumor suppressor for RCC, providing a potential attractive therapeutic approach for this malignancy.

Keywords

References

  1. Amit D, Hochberg A(2010). Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences. J Transl Med, 8, 134. https://doi.org/10.1186/1479-5876-8-134
  2. Birney E, Stamatoyannopoulos JA, Dutta A, et al (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816. https://doi.org/10.1038/nature05874
  3. Cho IC, Chung J (2012). Current status of targeted therapy for advanced renal cell carcinoma. Korean J Urol, 53, 217-28. https://doi.org/10.4111/kju.2012.53.4.217
  4. Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr. (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31. https://doi.org/10.1001/jama.281.17.1628
  5. Gibb EA, Brown CJ, Lam WL(2011). The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 38. https://doi.org/10.1186/1476-4598-10-38
  6. Gutschner T, Diederichs S (2012).The Hallmarks of Cancer: A long non-coding RNA point of view. RNA Biol, 9, 703-19. https://doi.org/10.4161/rna.20481
  7. Hasenpusch G, Pfeifer C, Aneja MK, et al (2011). Aerosolized BC-819 inhibits primary but not secondary lung cancer growth. PLoS One, 6, e20760. https://doi.org/10.1371/journal.pone.0020760
  8. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK (2006). Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst, 98, 1331-4. https://doi.org/10.1093/jnci/djj362
  9. Huarte M, Rinn JL (2010). Large non-coding RNAs: missing links in cancer? Hum Mol Genet, 19, R152-61. https://doi.org/10.1093/hmg/ddq353
  10. Ito S, Koshikawa N, Mochizuki S, Takenaga K (2007). 3-Methyladenine suppresses cell migration and invasion of HT1080 fibrosarcoma cells through inhibiting phosphoinositide 3-kinases independently of autophagy inhibition. Int J Oncol, 31, 261-8.
  11. Janzen NK, Kim HL, Figlin RA, Belldegrun AS (2003). Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am, 30, 843-52. https://doi.org/10.1016/S0094-0143(03)00056-9
  12. Kapranov P, St Laurent G, Raz T, et al (2010). The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol, 8, 149. https://doi.org/10.1186/1741-7007-8-149
  13. Liang P, Pardee AB (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-71. https://doi.org/10.1126/science.1354393
  14. Linehan WM, Walther MM, Alexander RB, Rosenberg SA (1993). Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute. Semin Urol, 11, 41-3.
  15. Ljungberg B, Campbell SC, Choi HY, et al (2006). The epidemiology of renal cell carcinoma. Eur Urol, 60, 615-21.
  16. Mercer TR, Dinger ME, Mattick JS (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet, 10, 155-9. https://doi.org/10.1038/nrg2521
  17. Mevorach RA, Segal AJ, Tersegno ME, Frank IN (1992). Renal cell carcinoma: incidental diagnosis and natural history: review of 235 cases. Urology, 39, 519-22. https://doi.org/10.1016/0090-4295(92)90006-I
  18. Mizrahi A, Czerniak A, Levy T, et al (2009). Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med, 7, 69. https://doi.org/10.1186/1479-5876-7-69
  19. Morrison LE, Jewell SS, Usha L, et al (2007). Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer. Genes Chromosomes Cancer, 46, 397-405. https://doi.org/10.1002/gcc.20419
  20. Mourtada-Maarabouni M, Hasan AM, Farzaneh F, Williams GT (2010). Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5). Mol Pharmacol, 78, 19-28. https://doi.org/10.1124/mol.110.064055
  21. Mourtada-Maarabouni M, Pickard MR, Hedge VL,et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208. https://doi.org/10.1038/onc.2008.373
  22. Muller AJ, Chatterjee S, Teresky A, Levine AJ (1998). The gas5 gene is disrupted by a frameshift mutation within its longest open reading frame in several inbred mouse strains and maps to murine chromosome 1. Mamm Genome, 9, 773-4. https://doi.org/10.1007/s003359900862
  23. Nie L, Wu HJ, Hsu JM, et al (2012). Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res, 4, 127-50.
  24. Nupponen NN, Carpten JD (2001). Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20, 155-64. https://doi.org/10.1023/A:1015557308033
  25. Raho G, Barone V, Rossi D, et al (2000). The gas 5 gene shows four alternative splicing patterns without coding for a protein. Gene, 256, 13-7. https://doi.org/10.1016/S0378-1119(00)00363-2
  26. Schneider C, King RM, Philipson L (1988). Genes specifically expressed at growth arrest of mammalian cells. Cell, 54, 787-93. https://doi.org/10.1016/S0092-8674(88)91065-3
  27. Sidi AA, Ohana P, Benjamin S, et al (2008). Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol, 180, 2379-83. https://doi.org/10.1016/j.juro.2008.08.006
  28. Smaldone MC, Davies BJ (2010). BC-819, a plasmid comprising the H19 gene regulatory sequences and diphtheria toxin A, for the potential targeted therapy of cancers. Curr Opin Mol Ther, 12, 607-16.
  29. Smedley D, Sidhar S, Birdsall S,et al (2000). Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer, 28, 121-5. https://doi.org/10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O
  30. Smith CM, Steitz JA (1998). Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol, 18, 6897-909.
  31. Soto-Vega E, Arroyo C, Richaud-Patin Y, et al (2009). P-glycoprotein activity in renal clear cell carcinoma. Urol Oncol,27, 363-6. https://doi.org/10.1016/j.urolonc.2008.01.011
  32. Tsai MC, Spitale RC, Chang HY (2011). Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res, 71, 3-7.
  33. van Spronsen DJ, Mulders PF, De Mulder PH (2005). Novel treatments for metastatic renal cell carcinoma. Crit Rev Oncol Hematol, 55, 177-91. https://doi.org/10.1016/j.critrevonc.2005.04.002
  34. Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23, 1494-504. https://doi.org/10.1101/gad.1800909

Cited by

  1. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer vol.54, pp.S1, 2013, https://doi.org/10.1002/mc.22120
  2. An emerging understanding of long noncoding RNAs in kidney cancer vol.140, pp.12, 2014, https://doi.org/10.1007/s00432-014-1699-y
  3. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy vol.145, pp.2, 2014, https://doi.org/10.1007/s10549-014-2974-y
  4. Functional Roles of Long Non-coding RNA in Human Breast Cancer vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.5993
  5. Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma vol.289, pp.3, 2014, https://doi.org/10.1007/s00438-013-0810-4
  6. Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer vol.31, pp.11, 2014, https://doi.org/10.1007/s12032-014-0253-8
  7. Genome-Wide Analysis of Long Noncoding RNA (lncRNA) Expression in Hepatoblastoma Tissues vol.9, pp.1, 2014, https://doi.org/10.1371/journal.pone.0085599
  8. The Long Non-Coding RNA GAS5 Cooperates with the Eukaryotic Translation Initiation Factor 4E to Regulate c-Myc Translation vol.9, pp.9, 2014, https://doi.org/10.1371/journal.pone.0107016
  9. Long non-coding RNA-GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C-C motif) ligand 1 expression vol.13, pp.1, 2016, https://doi.org/10.3892/mmr.2015.4503
  10. Role of long noncoding RNAs in malignant disease (Review) vol.13, pp.2, 2015, https://doi.org/10.3892/mmr.2015.4711
  11. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin vol.13, pp.2, 2015, https://doi.org/10.3892/mmr.2015.4716
  12. Long Non-coding RNAs are Differentially Expressed in Hepatocellular Carcinoma Cell Lines with Differing Metastatic Potential vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10513
  13. Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA vol.290, pp.47, 2015, https://doi.org/10.1074/jbc.M115.683813
  14. Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets vol.3, pp.1, 2015, https://doi.org/10.1186/s40591-015-0042-6
  15. Focusing on long noncoding RNA dysregulation in gastric cancer vol.36, pp.1, 2015, https://doi.org/10.1007/s13277-014-2894-9
  16. TE composition of human long noncoding RNAs and their expression patterns in human tissues vol.37, pp.1, 2015, https://doi.org/10.1007/s13258-014-0232-7
  17. Prognostic role of the long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 in various cancers: A meta-analysis vol.4, pp.1, 2015, https://doi.org/10.3892/mco.2015.657
  18. miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5 vol.48, pp.3, 2015, https://doi.org/10.1111/cpr.12181
  19. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer vol.5, pp.1, 2015, https://doi.org/10.1038/srep10159
  20. Molecular and Cellular Mechanisms of Action of Tumour Suppressor GAS5 LncRNA vol.6, pp.3, 2015, https://doi.org/10.3390/genes6030484
  21. Long non‑coding RNA growth arrest-specific transcript�5 in tumor biology (Review) pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3553
  22. Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9 vol.11, pp.4, 2016, https://doi.org/10.3892/etm.2016.3050
  23. Nrdp1-mediated degradation of BRUCE decreases cell viability and induces apoptosis in human 786-O renal cell carcinoma cells vol.12, pp.2, 2016, https://doi.org/10.3892/etm.2016.3356
  24. Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells vol.14, pp.1, 2016, https://doi.org/10.3892/mmr.2016.5337
  25. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis vol.15, pp.1, 2016, https://doi.org/10.1186/s12943-016-0545-z
  26. Long Non-coding RNAs and Drug Resistance vol.16, pp.18, 2015, https://doi.org/10.7314/APJCP.2015.16.18.8067
  27. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma vol.37, pp.1, 2016, https://doi.org/10.1007/s13277-015-3887-z
  28. LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway vol.37, pp.12, 2016, https://doi.org/10.1007/s13277-016-5429-8
  29. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4521-9
  30. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21 vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4111-x
  31. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-4189-1
  32. Long non-coding RNA GAS5 controls human embryonic stem cell self-renewal by maintaining NODAL signalling vol.7, pp.2041-1723, 2016, https://doi.org/10.1038/ncomms13287
  33. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis pp.2041-2657, 2016, https://doi.org/10.1093/bfgp/elw011
  34. Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p vol.12, pp.11, 2017, https://doi.org/10.1371/journal.pone.0184746
  35. Long noncoding RNA identification in lymphoma vol.13, pp.27, 2017, https://doi.org/10.2217/fon-2017-0230
  36. Downregulation of a novel long non-coding RNA, LOC389332, is associated with poor prognosis and tumor progression in clear cell renal cell carcinoma vol.13, pp.3, 2017, https://doi.org/10.3892/etm.2017.4080
  37. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma vol.18, pp.8, 2017, https://doi.org/10.3390/ijms18081774
  38. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer vol.27, pp.6, 2017, https://doi.org/10.1097/IGC.0000000000001028
  39. LncRNA UCA1 promotes renal cell carcinoma proliferation through epigenetically repressing p21 expression and negatively regulating miR-495 vol.39, pp.5, 2017, https://doi.org/10.1177/1010428317701632
  40. Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma vol.57, pp.1, 2017, https://doi.org/10.1002/mc.22739
  41. affecting hematopoietic reconstitution vol.58, pp.8, 2017, https://doi.org/10.1080/10428194.2016.1266626
  42. Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis vol.7, pp.1, 2017, https://doi.org/10.1186/s13578-017-0192-0
  43. Identification of a novel lncRNA induced by the nephrotoxin ochratoxin A and expressed in human renal tumor tissue pp.1420-9071, 2017, https://doi.org/10.1007/s00018-017-2731-6
  44. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma vol.17, pp.4, 2016, https://doi.org/10.3390/ijms17040573
  45. Long Noncoding RNAs Regulate Cell Growth, Proliferation, and Apoptosis vol.35, pp.9, 2016, https://doi.org/10.1089/dna.2015.3187
  46. Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6563
  47. Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma vol.16, pp.4, 2017, https://doi.org/10.3892/mmr.2017.7135
  48. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7470
  49. ElncRNA1, a long non-coding RNA that is transcriptionally induced by oestrogen, promotes epithelial ovarian cancer cell proliferation vol.51, pp.2, 2017, https://doi.org/10.3892/ijo.2017.4030
  50. Long Non-Coding RNAs in Multiple Myeloma vol.9, pp.2, 2018, https://doi.org/10.3390/genes9020069
  51. Long non-coding RNA Gas5 regulates proliferation and apoptosis in HCS-2/8 cells and growth plate chondrocytes by controlling FGF1 expression via miR-21 regulation vol.25, pp.1, 2018, https://doi.org/10.1186/s12929-018-0424-6
  52. Non-coding RNAs, epigenetics, and cancer: tying it all together vol.37, pp.1, 2018, https://doi.org/10.1007/s10555-017-9715-8
  53. miR-384 suppressed renal cell carcinoma cell proliferation and migration through targeting RAB23 pp.07302312, 2018, https://doi.org/10.1002/jcb.27180
  54. New advances of lncRNAs in liver fibrosis, with specific focus on lncRNA-miRNA interactions vol.234, pp.3, 2018, https://doi.org/10.1002/jcp.27069
  55. Emerging role of long non-coding RNA in the development of gastric cancer vol.10, pp.9, 2018, https://doi.org/10.4251/wjgo.v10.i9.260
  56. Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A vol.37, pp.9, 2018, https://doi.org/10.1089/dna.2018.4215
  57. Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma vol.6, pp.2167-8359, 2018, https://doi.org/10.7717/peerj.5124
  58. Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma vol.7, pp.7, 2018, https://doi.org/10.1002/cam4.1524
  59. Long noncoding RNA hypoxia-inducible factor 1 alpha-antisense RNA 1 promotes tumor necrosis factor-α-induced apoptosis through caspase 3 in Kupffer cells vol.97, pp.4, 2018, https://doi.org/10.1097/MD.0000000000009483
  60. Epigenetics in renal cell cancer: mechanisms and clinical applications vol.15, pp.7, 2018, https://doi.org/10.1038/s41585-018-0023-z
  61. lncRNAs in cancer-free breast tissue: Molecular associations with age at menarche and obesity pp.1075122X, 2018, https://doi.org/10.1111/tbj.13067
  62. Integrative analysis of gene expression and DNA methylation using unsupervised feature extraction for detecting candidate cancer biomarkers vol.16, pp.02, 2018, https://doi.org/10.1142/S0219720018500063
  63. Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia vol.109, pp.4, 2018, https://doi.org/10.1111/cas.13519
  64. Microarray expression profiling and co-expression network analysis of circulating LncRNAs and mRNAs associated with neurotoxicity induced by BPA vol.25, pp.15, 2018, https://doi.org/10.1007/s11356-018-1678-y
  65. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer vol.10, pp.3, 2019, https://doi.org/10.1038/s41419-019-1331-9
  66. Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21/SOX5 pathway vol.18, pp.3, 2019, https://doi.org/10.1080/15384101.2018.1475826
  67. Progress in research of long non-coding RNA GAS5 in human tumors vol.27, pp.3, 2019, https://doi.org/10.11569/wcjd.v27.i3.175
  68. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway vol.18, pp.1, 2019, https://doi.org/10.1186/s12943-019-0942-1